Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2

Human Genetics

Volumn 131, Issue 12, 2012, Pages 1869-1876

  Ibrahim Verbaas, Carla A ^a   Zorkoltseva, Irina V ^b   Amin, Najaf ^a   Schuur, Maaike ^a   Coppus, Antonia M W ^a   Isaacs, Aaron ^a,c   Aulchenko, Yurii S ^a   Breteler, Monique M B ^a   Ikram, M Arfan ^a   Axenovich, Tatiana I ^b   Verbeek, Marcel M ^d   Van Swieten, John C ^a   Oostra, Ben A ^a   Van Duijn, Cornelia M ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; HEMOGLOBIN A1C; PRESENILIN 2;

ADULT; AGED; ARTICLE; BODY MASS; CHROMOSOME 1; CHROMOSOME 11Q; CHROMOSOME 15Q; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; HERITABILITY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; COHORT STUDIES; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LOD SCORE; MALE; MIDDLE AGED; NETHERLANDS; PEPTIDE FRAGMENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRESENILIN-2;

EID: 84871012849     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1210-2     Document Type: Article

References (41)

1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97-101
2. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211
3. Anderson BM, Schnetz-Boutaud NC, Bartlett J, Wotawa AM, Wright HH, Abramson RK, Cuccaro ML, Gilbert JR, Pericak-Vance MA, Haines JL (2009) Examination of association of genes in the serotonin system to autism. Neurogenetics 10:209-216
4. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM (2007) GenABEL: An R library for genome-wide association analysis. Bioinformatics 23:1294-1296
5. Aznar S, Knudsen GM (2011) Depression and Alzheimer's disease: Is stress the initiating factor in a common neuropathological cascade? J Alzheimers Dis 23:177-193
6. Bettens K, Sleegers K, Van Broeckhoven C (2010) Current status on Alzheimer disease molecular genetics: From past, to present, to future. Hum Mol Genet 19:R4-R11
7. Demirkan A, Penninx BW, Hek K, Wray NR, Amin N, Aulchenko YS, van Dyck R, de Geus EJ, Hofman A, Uitterlinden AG, Hottenga JJ, Nolen WA, Oostra BA, Sullivan PF, Willemsen G, Zitman FG, Tiemeier H, Janssens AC, Boomsma DI, van Duijn CM, Middeldorp CM (2011) Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry 16:773-783
8. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, Taylor J, Burnett E, Gut I, Farrall M, Lathrop GM, Abecasis GR, Cookson WO (2007) A genome-wide association study of global gene expression. Nat Genet 39:1202-1207
9. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290:2303-2304
10. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Adamson J, Schaid DJ, Blangero J, Hutton M, Younkin SG (2001) Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees. Genet Epidemiol 21:19-30
11. Ertekin-Taner N, Younkin LH, Yager DM, Parfitt F, Baker MC, Asthana S, Hutton ML, Younkin SG, Graff-Radford NR (2008) Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology 70:596-606
12. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS, Read T, Murphy P, Blaveri E, McQuillin A, Petursson H, Curtis D (2001) Genomewide genetic linkageanalysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661-673
13. Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K (2010) Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 31:357-367
14. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC (2007) The Rotterdam Study: Objectives and design update. Eur J Epidemiol 22:819-829
15. Jayadev S, Case A, Eastman AJ, Nguyen H, Pollak J, Wiley JC, Moller T, Morrison RS, Garden GA (2010) Presenilin 2 is the predominant gamma-secretase in microglia and modulates cytokine release. PLoS ONE 5:e15743
16. Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimer's disease-friend or foe? Trends Neurosci 32:619-628
17. Kester MI, Verwey NA, van Elk EJ, Scheltens P, Blankenstein MA (2010) Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging 31:539-540
18. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, Corsmit E, Cruts M, Dermaut B, Wang R, Van Broeckhoven C (2006) Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 27:686-695
19. Lachno DR, Vanderstichele H, De GG, Kostanjevecki V, De Meyer G, Siemers ER, Willey MB, Bourdage JS, Konrad RJ, Dean RA (2009) The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma betaamyloid isoforms using the INNO-BIA plasma Abeta forms multiplex assay. J Nutr Health Aging 13:220-225
20. Lambert JC, Schraen-Maschke S, Richard F, Fievet N, Rouaud O, Berr C, Dartigues JF, Tzourio C, Alperovitch A, Buee L, Amouyel P (2009) Association of plasma amyloid beta with risk of dementia: The prospective Three-City Study. Neurology 73:847-853
21. Lambert JC, Dallongeville J, Ellis KA, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters CL, Rowe CC, Szoeke C, Tzourio C, Dartigues JF, Buee L, Martins R, Amouyel P (2011) Association of plasma Abeta peptides with blood pressure in the elderly. PLoS ONE 6:e18536
22. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
23. Li Y, Willer C, Sanna S, Abecasis G (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10:387-406
24. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816-834
25. Liu F, Arias-Vasquez A, Sleegers K, Aulchenko YS, Kayser M, Sanchez-Juan P, Feng BJ, Bertoli-Avella AM, van Swieten J, Axenovich TI, Heutink P, Van Broeckhoven C, Oostra BA, van Duijn CM (2007) A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am J Hum Genet 81:17-31
26. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330:1774
27. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
28. Murphy MP, LeVine H III (2010) Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis 19:311-323
29. Petit J, Boisseau P, Taine L, Gauthier B, Arveiler B (1999) A YAC contig encompassing the 11q14.3 breakpoint of a translocation associated with schizophrenia, and including the tyrosinase gene. Mamm Genome 10:649-652
30. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778
31. Schol-Gelok S, Janssens AC, Tiemeier H, Liu F, Lopez-Leon S, Zorkoltseva IV, Axenovich TI, van Swieten JC, Uitterlinden AG, Hofman A, Aulchenko YS, Oostra BA, van Duijn CM (2010) A genome-wide screen for depression in two independent Dutch populations. Biol Psychiatry 68:187-196
32. Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, Wattez A, David JP, Vanmechelen E, Sergheraert C, Delacourte A (2003) Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem 85:1581-1591
33. Shah NS, Vidal JS, Masaki K, Petrovitch H, Ross GW, Tilley C, DeMattos RB, Tracy RP, White LR, Launer LJ (2012) Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: The Honolulu Asia Aging Study. Hypertension 59:780-786
34. St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, Foncin JF, Montesi M, Bruni A, Sorbi S (1992) Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 2:330-334
35. Takashima A (2009) Amyloid-beta, tau, and dementia. J Alzheimers Dis 17:729-736
36. Thambisetty M, Tripaldi R, Riddoch-Contreras J, Hye A, An Y, Campbell J, Sojkova J, Kinsey A, Lynham S, Zhou Y, Ferrucci L, Wong DF, Lovestone S, Resnick SM (2010) Proteome-based plasma markers of brain amyloid-beta deposition in nondemented older individuals. J Alzheimers Dis 22(4):1099-1109
37. Van Broeckhoven C (1995) Presenilins and Alzheimer disease. Nat Genet 11:230-232
38. van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM (2006) Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: A prospective case-cohort study. Lancet Neurol 5:655-660
39. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L (2006) Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11:1, 18-1, 28
40. Willer CJ, Li Y, Abecasis GR (2010) METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26:2190-2191
41. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, Clark TA, Chen TX, Schweitzer AC, Blume JE, Cox NJ, Dolan ME (2008) Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 82:631-640